News Pfizer, Valneva Lyme vaccine starts review in Europe After reporting mixed clinical results in a phase 3 trial, Pfizer and Valneva have filed their Lyme disease vaccine candidate PF-07307405 in the EU.
News SNIPR phage therapy clears MDR infection in first patient A kidney transplant patient with a resistant infection is the first to be treated using a bacteriophage therapy developed by Denmark's SNIPR Biome.
News England close to eliminating hep C thanks to treatment drive England is on track to be one of the first countries in the world to eliminate hepatitis C, thanks to a national diagnosis and treatment programme.
News Trump order upturns federal childhood vaccines policy Trump has signed an order that rips up the current US policy on childhood vaccines, demanding changes that experts say will put children at risk.
News Moderna starts first trial of its Bundibugyo Ebola vaccine Moderna has started first-in-human testing of its mRNA vaccine against Bundibugyo Ebola virus, as the outbreak in DRC gathers pace.
News Simple blood test could aid in global TB fight A blood test for tuberculosis that can distinguish between dormant and active infections has shown promise in a clinical trial.
News After failure in sickle cell, Fulcrum merges with Slate Following the failure of its sickle cell programme, Fulcrum Therapeutics will merge with Slate Medicines to advance Slate's migraine therapy.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.